RxDoctor Payments Data

Jordan Fruchey, PA

Physician Assistant · Chicago, ILNPI 1558719773

Payments from drug & device makers

$1,334in general payments, 2019–2025

Across 48 payments — averaging $27.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$476
  • Novartis$323
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$217
  • Shockwave Medical, Inc$46
  • Abiomed$37
  • Pfizer$32
  • plus $202 from 8 others

What the payments were for

  • Food & beverage$1,334100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,334 in reported general payments places this provider in the 75th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$68,649
Medicare patients
265
Services billed
849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan159$233,144
JardianceEmpagliflozin178$201,189
EliquisApixaban67$72,455
FarxigaDapagliflozin Propanediol56$61,514
Bumetanide170$8,339
Metoprolol Succinate201$3,776
Spironolactone179$1,775
Eplerenone24$1,764
Atorvastatin Calcium115$1,250
Carvedilol98$1,179
Isosorbide Dinitrate14$917
Losartan Potassium53$644
Nifedipine ErNifedipine15$528
Rosuvastatin Calcium15$483
Amiodarone Hcl21$375

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$323$233,144159 claims
Boehringer IngelheimJardiance$29$201,189178 claims
PfizerEliquis$32$72,45567 claims
AstraZenecaFarxiga$17$61,51456 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →